Riskpilot← Back to searchSign inGet full accessCenvigo AB
ABActiveOrg 5592611312Ekeby Bruk 2 NResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20201 employees
Revenue 2025
SEK 0
EBITDA margin
—
-23% vs 2024
Equity ratio
57.7%
Financial strength
Net profit 2025
SEK -893K
-32% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -1,2M | -23% |
| Net profit | SEK -893K | -32% |
| Total assets | SEK 296K | -30% |
| Equity | SEK 171K | -53% |
| Employees | 1 | — |
Legal name
Cenvigo AB
Org number
5592611312
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29 juni 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska utveckla och sälja produkter och utföra konsulttjänster inom e-hälso och life science området samt för dessa förenlig verksamhet.
Address
Ekeby Bruk 2 N
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | −1 210 | −1 210 | −234 | −150 |
| EBITDA | −1 751 | −1 799 | −1 527 | −948 | −1 163 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −1 751 | −1 799 | −1 527 | −948 | −1 163 |
| Net financials | — | −0 | −1 | −0 | 0 |
| Profit before tax | −1 751 | −949 | −1 466 | −678 | −893 |
| Tax | −0 | — | — | — | — |
| Net profit | −1 751 | −949 | −1 466 | −678 | −893 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 198 | 305 | 337 | 424 | 296 |
| Equity | 96 | 197 | 231 | 363 | 171 |
| Long-term debt | 11 | 2 | 2 | 0 | — |
| Short-term debt | 91 | 107 | 103 | 60 | 125 |
| Total debt | 102 | 108 | 106 | 60 | 125 |
EBITDA margin
-116291300.0%
This company
15.8%
Market median
-736020986% vs market
20212025
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
20212025
Return on equity
-523.6%
This company
18.4%
Market median
-2946% vs market
20212025
Net profit margin
-89286900.0%
This company
8.1%
Market median
-1102307507% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Piconomy AB
Cenvigo AB Board members of Cenvigo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Runa Matsson | Deputy Board Member | 0 companies |
| Per Nils Jesper Matsson | Board of Directors | 0 companies |